Elpida

DRUG2 trials

Sponsors

Viriom

Conditions

HIV Infections

Phase 1

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

ViriomHIV Infections

Start: 2019-05-31End: 2019-12-31Target: 24Updated: 2019-05-20

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

CompletedNCT05204121

ViriomHIV Infections

Start: 2018-12-18End: 2019-04-02Updated: 2022-01-24